Psychedelic Stock Goes Nuts
This biotech stock focused on psychedelics is seeking to disrupt the mental health market.
Click here for the full story

LSH Insider Trading (Lifespot Health)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Lifespot Health Insider Trading History Chart

Lifespot Health Share Price & Price History

A$0.00
+0.30 (1.20%)
As of 11/1/2019 01:00 AM ET
Which Medical Cannabis Stocks Are About to Bring Stunning Profits To Investors?
Investors who jumped on the boom in medical cannabis stocks have made surprising profits over the last 3 years. In fact, since 2017, 21 medical cannabis stocks have soared by more than 1,000% .

And with medical cannabis sales expected to quintuple by 2026, investors still have lucrative opportunities.
Get This One on Your Radar Before Its Too Late

Lifespot Health Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/5/2021Rodney HanningtonInsiderIssued55,000A$0.07A$3,850.00
7/24/2020Rodney HanningtonInsiderIssued151,515A$0.03A$5,000.00
6/5/2019Rodney HanningtonInsiderIssued1,000,000A$0.07A$71,000.00
See Full Table
Lifespot Health logo
Lifespot Health Ltd, together with its subsidiaries, focuses on the development and commercialization of medical diagnostic and monitoring technology solutions in Australia and Germany. The company is developing the BodyTel System that integrates multiple sensors for capturing diagnostic information for additional diseases; and Seng-Vital, a digitally integrated cannabis vaporizer system. Lifespot Health Ltd is based in Melbourne, Australia.
Read More

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

120,633 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Lifespot Health?

Lifespot Health's top insider investors include:
  1. Rodney Hannington (Insider)
Exploding CBD Market For Pampered Pets
The year’s top cannabis play is likely not a pot stock. It’s a seed-to-sale cannabis company that makes CBD from hemp. This company grows what it says is the world’s most CBD-rich hemp. Among its array of pure CBD products are those aimed at the health of American pets. It’s worth a look because that will soon be a $2 billion market.
We’ve Got A Soft Spot For Our Pets, Check It Out